Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Synthetic Biologics Inc announces exercise of underwriters' over-allotment option

Friday, 13 Dec 2013 05:09pm EST 

Synthetic Biologics Inc:Says the exercise of the over-allotment option granted to the underwriters to purchase an additional 1,725,000 shares of its common stock, at a price to the public of $1.00 per share.Says in connection with the company's recently announced underwritten public offering of 11,500,000 shares of common stock, bringing total gross proceeds from the offering to $13,225,000, before underwriting discounts and commissions and other offering expenses payable by the company.Says Aegis Capital Corp. is acting as sole book-running manager for the offering. 

Company Quote

0.02 +1.33%
19 Dec 2014